Free Trial

EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Update

EUDA Health logo with Medical background

EUDA Health Holdings Limited (NASDAQ:EUDA - Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 19,900 shares, a growth of 33.6% from the December 15th total of 14,900 shares. Currently, 0.1% of the company's shares are sold short. Based on an average daily volume of 86,300 shares, the days-to-cover ratio is currently 0.2 days.

Analyst Upgrades and Downgrades

Separately, Greenridge Global raised shares of EUDA Health to a "strong-buy" rating in a research note on Monday, December 23rd.

Read Our Latest Analysis on EUDA Health

EUDA Health Stock Performance

EUDA Health stock traded down $0.11 during trading hours on Thursday, hitting $3.76. 100,804 shares of the stock traded hands, compared to its average volume of 106,200. EUDA Health has a one year low of $1.20 and a one year high of $6.30. The firm's 50-day moving average price is $4.51 and its two-hundred day moving average price is $4.19.

About EUDA Health

(Get Free Report)

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUDA Health Right Now?

Before you consider EUDA Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUDA Health wasn't on the list.

While EUDA Health currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines